Researchers at the University of Missouri School of Medicine in Columbia tested an FDA-approved medical device designed to speed up autism diagnoses in areas with limited access to specialty care.
The tool uses AI to analyze patient data and produce a positive, negative or indeterminate autism diagnosis, according to a Dec. 18 news release from the university.
The team integrated the tool, CanvasDx, into Missouri’s ECHO Autism program, which trains primary care clinicians to deliver autism care in underserved areas. In a study of 80 children, CanvasDx delivered determinate results in 52% of cases and aligned with clinician diagnoses, yielding no false positives or false negatives.
Travel to specialty care centers averaged 97 miles, but the study found that using CanvasDx locally allowed families to receive a diagnosis five to seven months sooner.
The post AI device shortens autism diagnosis time: Study appeared first on Becker’s Hospital Review | Healthcare News & Analysis.
Health IT
